When was Ergomed founded?

Ergomed was founded in 1997 and raised its 1st funding round 8 years after it was founded.

Where is Ergomed located?

Ergomed is headquartered in Guildford, United Kingdom. It is registered at 1 OCCAM COURT,SURREY RESEARCH PARK,GUILDFORD,ENGLAND,GU2 7HJ.

Who is the current CEO of Ergomed?

Gabriel Ibarra Mejia of Ergomed.

How many employees does Ergomed have?

As of May 31, 2026, the latest employee count at Ergomed is 720.

Is Ergomed a funded company?

Ergomed is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2005.

When was the latest funding round of Ergomed?

Ergomed's latest funding was a $***** Post IPO round on Feb 01, 2018, with participation from 0 investor.

What is the annual revenue of Ergomed?

Annual revenue of Ergomed is between £100M and £500M as on Dec 31, 2022

Where does Ergomed rank among its competitors?

Ergomed ranks 23rd amongst 341 active competitors, of which 14 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ClinChoice, which secured $150M in Jul, 2022.

Who are the top competitors of Ergomed?

Ergomed's top competitors include TFS, Parexel and Celgene. Among them, ClinChoice secured the most recent funding round in July, 2022.

Ergomed - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Ergomed an acquired company?

Ergomed got acquired by Permira on Sep 04, 2023.

Ergomed is an acquired company based in Guildford (United Kingdom), founded in 1997. It operates as a Clinical CRO specializing in oncology and rare diseases. Ergomed has raised an undisclosed amount in funding. The company has 341 active competitors, including 14 funded and 114 that have exited. Its top competitors include companies like TFS, Parexel and Celgene.

Company Details

Ergomed is a CRO operating in 50+ countries with two complementary businesses. As part of its co-development business, the company offers drug development services in exchange for revenues and out-licensing milestones w.r.t the sale and development of the product. The company has signed 5 such deals so far with different pharma companies. The company has acquired Haemostatix, along with a pipeline of proprietary development products for haemostasis in surgical settings.

Website: ergomedplc.com
Registered Address: 1 OCCAM COURT,SURREY RESEARCH PARK,GUILDFORD,ENGLAND,GU2 7HJ

Key Metrics

Founded Year

1997

Location

Guildford, United Kingdom

Stage

Acquired

Latest Funding Round

Post IPO, Feb 01, 2018, $*****

Investors

Catapult Ventures

Ranked

23^rd among 341 active competitors

Annual Revenue

£100M - £500M as on Dec 31, 2022

Employee Count

720 as on May 31, 2026

Investment & Acquisitions

Panacea & 10 more

Similar Companies

TFS & 406 more

Exit Details

Acquired by Permira (Sep 04, 2023)

View Ergomed's full profile

Ergomed is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Ergomed Clinical Research India Private Limited CIN: U73200PN2013PTC244709 , India, Active	Nov 05, 2013	$1M - $10M (As on Mar 31, 2025)	97 (As on Mar 31, 2024)
ERGOMED PLC CIN: 4081094 , United Kingdom, Active	Sep 28, 2000	$100M - $500M (As on Dec 31, 2022)	1437 (As on Jan 31, 2022)

Ergomed got acquired by Permira on Sep 04, 2023 at an acquisition amount of $*****.

Click here to take a look at Ergomed's acquisition in detail

Ergomed has raised funding over 2 rounds. Its first funding round was on 2005. Ergomed has 1 institutional investor.

Here is the list of recent funding rounds of Ergomed:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 01, 2018	5357396	Post IPO	6150031	7522528	6133145	2125506
2005	9105	Series A	4767	5866	6646	Catapult Ventures

Access funding benchmarks and valuations. Sign up today!

View details of Ergomed's funding rounds and investors

Ergomed's employee count trend

Ergomed has 720 employees as of May 26. Here is Ergomed's employee count trend over the years:

Uncover Ergomed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ergomed include TFS, Parexel and Celgene. Here is the list of Top 10 competitors of Ergomed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TFS 1996, Lund (Sweden), Acquired	A global mid-service CRO providing clinical research services	-	-	63/100
2nd	Parexel 1983, Waltham (United States), Acquired	Global full-service CRO	-	Vedanta Capital, Boston Capital Ventures & 2 others	62/100
3rd	Celgene 1986, Summit (United States), Acquired	Developer of therapies for treating cancer and inflammatory diseases	$45M	Piper Jaffray, BB Biotech & 12 others	61/100
4th	Veristat 1994, Southborough (United States), Acquired	Clinical research organization accelerating complex therapies through strategic planning and execution	-	Variance Development Partners, WindRose Health Investors ... & 2 others	60/100
5th	Siro Clinpharm 2000, Thane (India), Acquired	Company offering clinical development services	$5.25M	Kotak Mahindra Bank, Baring Private Equity Partners ... & 4 others	60/100
6th	Syneos Health 1984, Raleigh (United States), Public	Provider of CRO clinical development	-	Adams Street Partners, First Analysis & 2 others	58/100
7th	Premier Research 1989, Durham (United States), Public	Provider of clinical trial CRO services	-	alzheimerlondon.ca, Metalmark Capital & 4 others	55/100
8th	Biorasi 2002, Miami (United States), Acquired	CRO delivering reliable, flexible, transparent clinical trials with scientific excellence	-	-	54/100
9th	ClinChoice 1995, Fort Washington (United States), Series E	CRO focused on data management, regulatory affairs and consulting services	$212M	Goldman Sachs, Legend Capital & 8 others	53/100
10th	Worldwide Clinical Trials 1986, Beverly Hills (United States), Acquired	Global CRO providing personalized support for clinical trials across diverse therapeutic areas	-	TJC, Scrip Awards	51/100
23rd	Ergomed 1997, Guildford (United Kingdom), Acquired	Clinical CRO specializing in oncology and rare diseases	-	Catapult Ventures	42/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Ergomed's competitors? Click here to see the top ones

Ergomed has made 1 investments in companies including Asarina Pharma. Ergomed has also acquired 10 companies including Panacea and ADAMAS Consulting.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 10, 2023	Acquisition	Panacea	2008	Douglas (United Kingdom)
Feb 09, 2022	Acquisition	ADAMAS Consulting	1997	Crowthorne (United Kingdom)
Dec 14, 2020	Acquisition	MedSource	1997	Houston (United States)